Literature DB >> 8695998

Fibreoptic phototherapy in the management of jaundice in low birthweight neonates.

G P Donzelli1, M Moroni, S Pratesi, G Rapisardi, G Agati, F Fusi.   

Abstract

A fibreoptic phototherapy device has been compared with conventional white and special blue fluorescent phototherapy lamps to evaluate its efficacy in lowering serum bilirubin levels in low-birthweight neonates. Fibreoptic phototherapy was found to be as effective as white light and less effective than blue light, as assessed by (i) the bilirubin concentration after 24 h of phototherapy and at the end of phototherapy, (ii) the duration of phototherapy, (iii) the percentage daily decline rate and (iv) the overall percentage decline rate (p < 0.05). There were no failures of phototherapy and the need for re-exposure was low (4.7% of the total sample), with no difference between groups. The fibreoptic approach represents a promising way to aggregate synergically the most recent optical technologies and develop a modern, efficient and caring phototherapy system for low-birthweight infants.

Entities:  

Mesh:

Year:  1996        PMID: 8695998     DOI: 10.1111/j.1651-2227.1996.tb14034.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  3 in total

Review 1.  Fibreoptic phototherapy for neonatal jaundice.

Authors:  J F Mills; D Tudehope
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 2.  Treatment of jaundice in low birthweight infants.

Authors:  M J Maisels; J F Watchko
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-11       Impact factor: 5.747

3.  Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: multi-center observational study.

Authors:  B H Morris; J E Tyson; D K Stevenson; W Oh; D L Phelps; T M O'Shea; G E McDavid; K P Van Meurs; B R Vohr; C Grisby; Q Yao; S Kandefer; D Wallace; R D Higgins
Journal:  J Perinatol       Date:  2012-04-12       Impact factor: 2.521

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.